Browse studies

Find your next paid study

1 recruiting study matching your filters

FORAGER-1: A Phase 1, Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Locally Advanced or Metastatic Solid Tumors Including Urothelial Cancer With FGFR3 Alterations

The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-435 by itself or when it is combined with other stand…

Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms

Eli Lilly and CompanyNCT05614739